HTAi 2008 :: Sessions plénières

L’ÉTS dans le contexte du processus de prise de décision, à tous les niveaux des réseaux de la santé, fera l’objet de différents ateliers et de sessions au cours de la conférence. Ces ateliers et sessions permettront aux participants d’échanger sur les meilleures méthodes et procédés dans le domaine de l’ÉTS. Un appel aux conférenciers pour les ateliers et les sessions sera lancé en octobre 2007.

La traduction simultanée vers le français, le portugais et l’espagnol n'est offerte que lors des sessions plénières.

À noter que la langue officielle de cette conférence est l'anglais; les titres et les résumés des présentations ne sont disponibles que dans cette langue.

HTA and governance in the Americas | L’ÉTS et la gouvernance dans les Amériques
Président : Reiner Banken, Canada

Lundi 7 juillet 2008

HTA AND GOVERNANCE IN THE AMERICAS
Chair:
Reiner Banken, Deputy Chief Executive Officer,
Development and Partnerships of the Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), Canada

Conférenciers :

1) Enrique Ruelas, Secretary of the National Health Council, Mexico
2) Renaldo Guimaraes, Secretary of Science, Technology and Strategic Inputs at the
Ministry of Health, Brazil
3) Patricia Meade, Deputy Minister of Health, Alberta, Canada
4) Steven D. Pearson, Senior Fellow, America’s Health Insurance Plans, USA

Health governance is about competently directing health system resources, performance, and stakeholder participation towards the goal of saving lives and improving population health. Evidence-informed decision making is essential for good health governance. In this context, HTA has emerged as a powerful tool for supporting effective decision making on different levels of health systems. How does HTA fit in with the authority and responsibilities of decision making on the national, the subnational and local levels in different health systems? What is the appropriate institutional context of HTA to contribute to effective governance and social credibility of decisions? Senior policy makers from Brazil, Mexico, the US and Canada will describe their respective health systems and the current and future role of HTA for effective policy making. The experience from these four very different health systems will provide lessons for HTA supporting good governance world wide.

CONDITIONAL COVERAGE AND EVIDENCE DEVELOPMENT FOR
PROMISING TECHNOLOGIES
Chair:
Sean Tunis, Director, Center for Medical Technology Policy, USA

Conférenciers :

1) Peter Litllejohns, Clinical and Public Health Director, National Institute for Health and Clinical Excellence (NICE), United Kingdom
2) Jean R. Slutsky, Director, Center for Outcomes and Evidence for the Agency for Healthcare Research and Quality, USA
3) Les Levin, Head, Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care, Canada
4) Sean Tunis, Director, Center for Medical Technology Policy, USA
5) Laurent Degos, President, Haute Autorité de Santé (HAS), France

New technologies are introduced at an ever increasing rate into health care systems, offering potential benefits to public health while also generally increasing costs. With continued pressures on healthcare budgets, innovative technologies are subject to increasing scrutiny before healthcare decision makers are willing to provide coverage for their use. Decisions for coverage are ideally based on reliable evidence of safety and effectiveness, but generating such evidence may impose expensive, lengthy evidence requirements.

Demands for definite evidence of benefit may be inconsistent with the pace at which technologies are developed, modified, and abandoned. Conditional coverage with evidence development for promising technologies has been explored as a new avenue to avoid “yes” or “no” decisions under uncertainty, while supporting the collection of the evidence needed by patients, clinicians and payers.

The success of this approach to date has been mixed. Leading experts from Europe and North America will discuss concepts, methods and best practice in conditional coverage with evidence development, addressing critical issues in science, policy, financing and operations.

Chair: Americo Cicchetti, Professor, Faculty of Economics, Università Cattolica S. Cuore, Italy

Conférenciers :

1) Guy Maddern, Chair, International Network of Agencies for Health Technology Assessment (INAHTA), Australia
2) Maurice McGregor, Chair, Technology Assessment Unit, McGill University Health Centre, Canada
3) Lars Dahl Pedersen, Head of Department, Health Care Planning Division, Central Region, Denmark

Rapporteur :

Renaldo Battista, Director, Department of Health Administration, Université de Montréal, Canada

Hospital-based HTA is a rapidly growing field in many countries. This plenary session will address some of the issues facing both HTA practitioners and decision makers at the level of health care organizations. Can HTA principles and tools enhance rationality in decision making regarding adoption and use of health technologies within health care organizations?

Which role hospitalbased HTA can and should play within mature health care systems?
Which links should be established among different levels of the health care systems to maximize the impact of HTA? Is it reasonable/useful to work towards the harmonization of hospital-based HTA practices in order to better share knowledge among countries? Speakers from North America, Europe and Australia will present different perspectives and provide some guidance to this emerging and promising field of application of HTA.